Inventor
MA ZHIHUA
US42 patents
⚠️ This page may combine multiple inventors who share the name “MA ZHIHUA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
28 patentsUS10221162B2Mar 5, 2019
Triazole agonists of the APJ receptor
AMGEN INC12 citations92
US10058550B2Aug 28, 2018
Methods of treating heart failure
AMGEN INC13 citations92
US9868721B2Jan 16, 2018
Triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9845310B2Dec 19, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9751864B2Sep 5, 2017
Methods for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9745286B2Aug 29, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9656997B2May 23, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9656998B2May 23, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9573936B2Feb 21, 2017
Triazole agonists of the APJ receptor
AMGEN INC19 citations92
US10150760B2Dec 11, 2018
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
AMGEN INC8 citations84
US9988369B2Jun 5, 2018
Heterocyclic triazole compounds as agonists of the APJ receptor
AMGEN INC8 citations83
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US7816367B2Oct 19, 2010
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
AMGEN INC15 citations83
US7649110B2Jan 19, 2010
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
AMGEN INC8 citations83
US7582803B2Sep 1, 2009
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
AMGEN INC17 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US7465804B2Dec 16, 2008
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
AMGEN INC3 citations63
US11046680B1Jun 29, 2021
Heteroaryl-substituted triazoles as APJ receptor agonists
AMGEN INC2 citations62
US10906890B2Feb 2, 2021
Triazole phenyl compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US10736883B2Aug 11, 2020
Triazole furan compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US10689367B2Jun 23, 2020
Triazole pyridyl compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US7687526B2Mar 30, 2010
Benzo-fused compounds for use in treating metabolic disorders
AMGEN INC5 citations62
US11020395B2Jun 1, 2021
Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
AMGEN INC1 citations61
US11191762B2Dec 7, 2021
Alkyl substituted triazole compounds as agonists of the APJ Receptor
AMGEN INC0 citations51
US11149040B2Oct 19, 2021
Fused triazole agonists of the APJ receptor
AMGEN INC0 citations51
US8003648B2Aug 23, 2011
Heterocyclic GPR40 modulators
AMGEN INC1 citations50
US7714008B2May 11, 2010
Heterocyclic GPR40 modulators
AMGEN INC0 citations50
TUSIMPLE INC
5 patentsUSD927581SAug 10, 2021
Holder for multiple cameras
TUSIMPLE INC5 citations84
USD918839SMay 11, 2021
Aviation socket
TUSIMPLE INC8 citations84
USD929487SAug 31, 2021
Holder for multiple cameras
TUSIMPLE INC1 citations73
US10973152B2Apr 6, 2021
Cooling system
TUSIMPLE INC1 citations73
USD903598SDec 1, 2020
Aviation plug
TUSIMPLE INC2 citations73